Organogenesis Holdings, Inc. (ORGO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BioLife Solutions, Inc.

IRadimed Corp.

Mesa Laboratories, Inc.

Orthofix Medical, Inc.

Outset Medical, Inc.

Surmodics, Inc.

AirSculpt Technologies, Inc.

Organogenesis Holdings, Inc.

Castle Biosciences, Inc.

OraSure Technologies, Inc.

Minerva Surgical, Inc.

Why is Organogenesis Holdings, Inc. ?

The company has declared negative results in Mar'2026 after 2 consecutive positive quarters

RAW MATERIAL COST(Y) Grown by 105.37% (YoY)
NET SALES(Q) Lowest at USD 37.23 MM
OPERATING PROFIT(Q) Lowest at USD -52.66 MM

Below par performance in long term as well as near term

Along with generating -25.38% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Organogenesis Holdings, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Organogenesis Holdings, Inc.

-25.38%

-0.11

77.03%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.77%

EBIT Growth (5y)

15.69%

EBIT to Interest (avg)

8.26

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

1.23

Tax Ratio

34.50%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

55.79%

ROCE (avg)

16.10%

ROE (avg)

15.16%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.68

EV to EBIT

3.88

EV to EBITDA

2.63

EV to Capital Employed

0.62

EV to Sales

0.39

PEG Ratio

0.05

Dividend Yield

ROCE (Latest)

15.86%

ROE (Latest)

11.19%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 30.76 MM

NET PROFIT(9M)

Higher at USD 18.74 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 5.98 times

-16What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 105.37% (YoY

NET SALES(Q)

Lowest at USD 37.23 MM

OPERATING PROFIT(Q)

Lowest at USD -52.66 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -141.46 %

PRE-TAX PROFIT(Q)

Lowest at USD -64.61 MM

NET PROFIT(Q)

Lowest at USD -49.3 MM

EPS(Q)

Lowest at USD -0.44

Here's what is working for Organogenesis Holdings, Inc.

Operating Cash Flow

Highest at USD 30.76 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Highest at 5.98 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

Highest at USD 12.37 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation

At USD 12.37 MM has Grown at 76.39%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for Organogenesis Holdings, Inc.

Net Sales

At USD 37.23 MM has Fallen at -73.61%

over average net sales of the previous four periods of USD 141.04 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -64.61 MM has Fallen at -537.39%

over average net sales of the previous four periods of USD 14.77 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -49.3 MM has Fallen at -506.17%

over average net sales of the previous four periods of USD 12.14 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

Lowest at USD 37.23 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit

Lowest at USD -52.66 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at -141.46 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at USD -64.61 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -49.3 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD -0.44

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Raw Material Cost

Grown by 105.37% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales